Stifel analysts maintained a Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA) with a steady price target of $21.00. According to InvestingPro data, the stock currently trades at $6.40, with analyst ...

The team of three advisors have started a firm called T6 Wealth Management, which will operate out of Morgan Stanley's new ...

Stifel Financial Corp (NYSE:SF). has announced a revision to its executive compensation structure, according to a recent SEC filing. On Monday, the Compensation Committee of the Board of Directors ...

Research analysts at Stifel Canada reduced their Q4 2024 earnings estimates for Kinross Gold in a report issued on Tuesday, ...

We recently compiled a list of the 12 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

Research analysts at Stifel Canada issued their Q4 2024 earnings estimates for shares of Franco-Nevada in a research note ...

Stifel Financial Corp. announced a cash dividend ... The Company’s Series B Preferred Stock trades on the New York Stock Exchange under the symbol “SF PrB”, the Company’s Series C ...

(RTTNews) - Stifel Financial Corp. (SF ... Inc. Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews ...

Stifel Financial Corp (SF) reports record net revenue and a significant increase in earnings per share, despite challenges in ...

In a report released today, Shlomo Rosenbaum from Stifel Nicolaus maintained a Buy rating on Equifax (EFX – Research Report), with a price ...